Medicare Enrolled
Dr. Christopher Ip, M.D.
Urology Physician · North Andover, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ip from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ip?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ip
Dr. Christopher Ip is an urology physician in North Andover, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ip performed 2,942 Medicare services across 1,728 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ip received a total of $5,212 from 40 pharmaceutical and/or device companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ip is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 33% volume in MA
$5,212 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,942
Medicare services
Top 33% in MA for urology physician
1,728
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~155 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
968 | $95 | $325 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
719 | $2 | $15 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
331 | $8 | $259 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
195 | $34 | $70 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
90 | $100 | $275 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
87 | $198 | $550 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
72 | $112 | $450 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
70 | $97 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
62 | $70 | $240 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 61 | $138 | $805 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
47 | $59 | $346 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
45 | $69 | $140 |
| Complicated insertion of bladder tube | 40 | $118 | $289 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
36 | $26 | $115 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
23 | $59 | $201 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
21 | $347 | $1,825 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
17 | $65 | $151 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $107 | $350 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
15 | $34 | $70 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
15 | $34 | $70 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
12 | $110 | $1,446 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
14.1% medium
84.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,212
Total received (2018-2024)
Avg $745/year across 7 years
Top 27% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
212
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,508 (86.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$704 (13.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$804
2023
$1,000
2022
$807
2021
$977
2020
$397
2019
$579
2018
$646
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$218
Ferring Pharmaceuticals Inc.
$168
Teleflex LLC
$99
Antares Pharma, Inc.
$82
Sumitomo Pharma America, Inc.
$75
ACCORD HEALTHCARE, INC.
$70
Tolmar, Inc.
$50
Myriad Genetic Laboratories, Inc.
$24
ABBVIE INC.
$18
Top 3 companies account for 60.2% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,726
Teleflex LLC
$675
Antares Pharma, Inc.
$266
Ferring Pharmaceuticals Inc.
$255
AbbVie, Inc.
$189
Sumitomo Pharma America, Inc.
$173
ABBVIE INC.
$158
Janssen Biotech, Inc.
$157
ACCORD HEALTHCARE, INC.
$144
TOLMAR Pharmaceuticals, Inc.
$116
AngioDynamics, Inc.
$107
Tolmar, Inc.
$103
KARL STORZ Endoscopy-America
$101
NeoTract Inc.
$96
AbbVie Inc.
$88
UROVANT SCIENCES INC
$72
Allergan, Inc.
$67
Myovant Sciences Inc.
$62
Accord Healthcare, Inc.
$61
Blue Earth Diagnostics Limited
$61
Supernus Pharmaceuticals, Inc.
$57
MEDIVATION FIELD SOLUTIONS LLC
$47
PFIZER INC.
$46
Alnylam Pharmaceuticals Inc.
$40
Merck Sharp & Dohme LLC
$34
Palette Life Sciences, Inc.
$33
Medtronic, Inc.
$32
PALETTE LIFE SCIENCES, INC.
$30
Coloplast Corp
$28
Avadel Specialty Pharmaceuticals, LLC
$24
Myriad Genetic Laboratories, Inc.
$24
Metuchen Pharmaceuticals
$23
Dendreon Pharmaceuticals LLC
$20
AMAG Pharmaceuticals, Inc.
$16
Boston Scientific Corporation
$16
Sun Pharmaceutical Industries Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
C. R. Bard, Inc. & Subsidiaries
$14
Teleflex Medical Incorporated
$12
AKRIMAX PHARMACEUTICALS, LLC
$10
Top 3 companies account for 51.2% of all-time payments
Associated products mentioned in payments ›
24FR BIPLR COAG ELECTRDE · ADSTILADRIN · Androgel · Axumin · BOTOX · BOTOX COSMETIC · CAMCEVI · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GIVLAARI · INTERSTIM · INTRAROSA · JATENZO · KEYTRUDA · LUPRON DEPOT · Ligation Solutions: Weck & Horizon brands · Lupron · Lupron Depot · MYRBETRIQ · MYRISK · Myrbetriq · NANOKNIFE · NOCDURNA · Noctiva · ORGOVYX · OTREXUP · PKG/6 · PROVENGE · SKYLITE · STERILE · SpaceOAR VUE System - 10mL · SpeediCath · Stendra · TLANDO · TOVIAZ · UROLIFT · UroLift · UroLift System · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
176
Per 100K population
21.8
County median income
$99,431
Nearest hospital
HOLY FAMILY HOSPITAL
6.5 mi
6.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ip is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ip experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ip performed 968 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ip receive payments from pharmaceutical companies?
Yes. Dr. Ip received a total of $5,212 from 40 companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ip's costs compare to other urology physicians in North Andover?
Dr. Ip's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ip) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in North Andover
Browse urology physicians in North Andover ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Antares Pharma, Inc. Payments to Doctors
See all physicians who received payments from Antares Pharma, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology